Granahan Investment Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$7,550,000
+4.0%
731,558
+6.0%
0.14%
-8.4%
Q1 2021$7,263,000
-6.6%
690,410
+37.4%
0.15%
-12.0%
Q4 2020$7,779,000
+99.1%
502,542
+87.7%
0.18%
+31.6%
Q3 2020$3,908,000
-52.9%
267,697
-38.9%
0.13%
-55.7%
Q2 2020$8,297,000438,0810.30%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders